Croatian tennis player Marin Cilic will reportedly appeal against his nine month doping ban, with which he has been hit after testing positive for a banned substance.
Cilic, who is currently ranked 24th in the world, had tested positive for the stimulant nikethamide at the Munich Open in Germany last April and will not return to action until February 1, 2014.
However, CNN reports that Cilic will now appeal against the decision in front of the Court of Arbitration for Sport by claiming that he unknowingly took the banned substance as he was unaware that the Coramine tablets contained nikethamide.
Insisting that he has never knowingly or deliberately taken any banned substances in his life, Cilic, who has had the ban backdated to May 1 this year, said in a statement that the banned substance originated from a glucose tablet which he had purchased at a French pharmacy in all innocence.
Cilic further stated that he is opposed to the use of any use of performance enhancing substances in sport, following which the tribunal ruled that Cilic will serve a reduced ban of nine months as they believed that he did not intend to 'enhance his performance' by taking the substance.
Following the ban, Cilic, who has not competed since withdrawing from Wimbledon citing a knee injury, had his Munich Open results obliterated and also had to forfeit both his prize money and rankings points from the event.
Cilic is the fourth tennis player to be hit with a ban for drug violations in 2013, following Serbian Viktor Troicki, Brazil's Fernando Romboli and Czech player Barbora Zahlavova Strycova, the report added.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
